Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
The model's full reasoning — Q1 2017 call → NOWe need to determine if management conveys that outsiders are currently underweighting something the company has already done, and points to a concrete, already-completed/operating piece of the business whose contribution is still largely ahead of reported results. Let's analyze the transcript. Key points from management: - Larry Wexler: "There's a lot to like about our performance in the first quarter and about the way the company continues to transform and prepare for future growth we're delivering on our strategies." - He mentions acquisitions, refinancing, etc. - He says: "We're progressing well on integrating our 2016 acquisitions. First, we are on schedule to expand retail distribution later this year of the five regional smokeless tobacco brands we acquired for Wind River. This great Plug-n-Play opportunity allows us to utilize our existing SG&A infrastructure and expand these regional brands beyond the 25% of the market where they're currently distributed." - He talks about VaporBeast: "VaporBeast gives us ready access to the non-traditional retail outlets [ph] and teen insights into the products and attributes consumers are choosing. This information helps us develop go to market plans to make TPV [ph] products to non-traditional retail through VaporBeast distribution platform. We're also strategizing to more fully expand some of their highly successful proprietary products. We're now focused on making growth and operational improvements across the business and have been very pleased with the early progress. It is important to understand that VaporBeast is a very young company as they were only founded in 2012. As such and given their early extraordinary growth trajectory did not have the opportunity to formalize and fully develop optimum selling, distribution or supplier processes. On selling strategies we're working collaboratively to bring best in class sales methodologies to the organization and to heighten the absolute effectiveness. Next as a swiftly growing organization they were forced to focus on the daily high hurdles of meeting demand and less on establishing strong supplier relations. We have joined leverage our supply chain experience to identifying not only operational efficiencies but also cost saving initiatives. Finally VaporBeast is a service business the success is linked to the excess of the retailers they serve.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
PRPH · Q1 2023 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES The transcript shows management explicitly framing the current market view as mismatched with the company's actual position: "Anybody that's focused on us for earnings, you invested or are following the wrong company," "we're not an earnings story this year," and "focus less on revenues and earnings. This is a transition year." They repeatedly contrast this with the multi-billion-dollar assets already built and operating, whose contributions are still ramping or largely ahead. Concrete already-real items with meaningful payoff still ahead include: - The manufacturing facility (already at capacity, running nearly 100% YoY growth, with $25M revenue target for 2024 constrained only by capacity expansion this year; estimated $70M valuation next year plus $40M working capital and tens of millions in equipment). - Nebula Genomics (already generating >100% YoY revenue growth via direct-to-consumer sales; in-house whole-genome processing and B2B ramp expected in H2 202 3, particularly Q4, after validations complete in a couple of months).
KEY · Q3 2022 → YESThe question is: Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE — and does management answer that gap by pointing to at least one CONCRETE, A...YES Management repeatedly frames its interest-rate-risk positioning as something that “sets Key apart” and creates “unique and significant upside” that is not yet reflected in the market’s view of the company. Chris Gorman states that the $1.2 billion annualized benefit from re-pricing existing short-term Treasuries and swaps “ even in the event that rates remain at current levels” will arrive over the next two years, and Don Kimble confirms the same mechanics and timing. The $9 billion in short-term Treasuries and $26 billion in swaps are already on the balance sheet; the contribution is simply not yet in the reported results.
KIM · Q2 2018 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES Management explicitly frames the public-private pricing disconnect as a gap in how the company is valued versus its actual assets and execution. They point to the already-completed Toys "R" Us liquidation process (22 boxes resolved into OpCo and PropCo leases, with seven OpCo leases already signed and seven PropCo under 18-24 month resolution) as a concrete, already-real item whose rent contribution is still largely ahead in the reported results, with the 70-80 bps impact on occupancy and same-site NOI expected to be recaptured in Q3 and beyond.